-
www.ahrq.gov/hai/cusp/toolkit/content-calls/assertion.html
April 01, 2013 - Appropriate Assertion Call (Transcript)
December 14, 2010
Operator: Good day, ladies and gentleman and welcome to the CUSP Content Call. At this time, all participants are in a listen only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. If anyone should …
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol3/Flink.pdf
April 09, 2004 - Lessons Learned from the Evolution of Mandatory Adverse Event Reporting Systems
135
Lessons Learned from the Evolution of
Mandatory Adverse Event Reporting Systems
Ellen Flink, C. Lynn Chevalier, Angelo Ruperto, Peg Dameron,
Frederick J. Heigel, Ruth Leslie, Janet Mannion, Robert J. Panzer
Abstract
New Yor…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol3/Advances-Dingley_14.pdf
February 06, 2008 - Improving Patient Safety Through Provider Communication Strategy Enhancements
Improving Patient Safety Through Provider
Communication Strategy Enhancements
Catherine Dingley RN, PhD, FNP; Kay Daugherty RN, PhD; Mary K. Derieg RN, DNP;
Rebecca Persing, RN, DNP
Abstract
The purpose of this study was to devel…
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-5.pdf
February 02, 2012 - a special con-
cern among adolescents58; clinicians
should monitor symptoms and
prescription-refill requests
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-5.pdf
February 02, 2012 - special con
cern among adolescents58; clinicians
should monitor symptoms and
prescription-refill requests
-
www.ahrq.gov/sites/default/files/publications2/files/diagnostic-safety-issue-brief-test-result-communication.pdf
July 01, 2024 - ■ We get a lot of requests like, “Why is my result one point above the normal range?”
-
www.ahrq.gov/sites/default/files/2025-02/raab-report.pdf
January 01, 2025 - despite their initial commitment to collaborate on this study with the knowledge that it would involve requests
-
www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/medical-office/2024-medical-office-database-report-rev.pdf
January 01, 2024 - index.html
2024 SOPS Medical Office Database Report 3
Purpose and Use of This Report
In response to requests
-
www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/medical-office/2022-mosops-database-report-part-I.pdf
January 01, 2022 - index.html
2022 SOPS Medical Office Database Report 3
Purpose and Use of This Report
In response to requests
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/NCINQTobaccoUseHelpForm.pdf
August 01, 2012 - NCINQ Measure Submission: Tobacco Use and Help with Quitting Among Adolescents
Attachment A: CHIPRA Pediatric Quality Measures Program (PQMP) Candidate
Measure Submission Form (CPCF)
Italics indicate instructions for how to complete a specific field. << >> indicates the name of a text field in the
online version o…
-
www.ahrq.gov/prevention/guidelines/tobacco/clinicians/references/quickref/index.html
October 01, 2014 - Treating Tobacco Use and Dependence
Quick Reference Guide for Clinicians
This Quick Reference Guide for Clinicians presents summary points from the Clinical Practice Guideline. The guideline provides a description of the development process, thorough analysis and discussion of the available research, critical…
-
www.ahrq.gov/sites/default/files/publications/files/cauti-interim.pdf
September 01, 2013 - Eliminating CAUTI: A National Patient Safety Imperative
Eliminating CAUTI:
A National Patient
Safety Imperative
Interim Data Report on the National
On the CUSP: Stop CAUTI Project
A Project of:
Health Research & Educational Trust
Michigan Health & Hospital Association Keystone Center for Patient Safety & Qua…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patientsafetyculture/asc/ascwebinar/ascwebcast0715_transcript.pdf
September 01, 2015 - Introducing the AHRQ Ambulatory Surgery Center Survey on Patient Safety Culture: Webcast Transcript
1
Introducing the AHRQ Ambulatory Surgery Center Survey on Patient Safety Culture
July 15, 2015 – Webcast Transcript
Speakers
Jim Battles, PhD, AHRQ Center for Quality Improvement and Patient Safety, Rockville, …
-
www.ahrq.gov/workingforquality/events/webinar-using-payment-to-improve-health-and-health-care-quality.html
November 01, 2016 - Webinar Transcript - National Quality Strategy: Using Payment to Improve Health and Health Care Quality
February 4, 2015
Download accessible version of slides (PDF, 1.5 MB)
National Quality Strategy Webinar: Using Payment to Improve Health and Health Care Quality. February 4, 2015 [Slide 1]
Operato…
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-2-attachment-1.pdf
February 01, 2012 - Measure 1, Section 2, Attachment 1
Attention Deficit Hyperactivity Disorder
Performance Measurement Set
Supported by AHRQ/CHIPRA-PQMP
Proposed by the ADHD Expert Work Group (listed in Appendix A)
In collaboration with the Pediatric Measurement Center of Excellence (PM…
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-2-attach-1.pdf
February 01, 2012 - Attention Deficit Hyperactivity Disorder Performance Measurement Set
Attention Deficit Hyperactivity Disorder
Performance Measurement Set
Supported by AHRQ/CHIPRA-PQMP
Proposed by the ADHD Expert Work Group (listed in Appendix A)
In collaboration with the Pediatric Meas…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-135-fullreport.pdf
February 01, 2017 - Timeliness of Antibiotic Prophylaxis for Children With Sickle Cell Disease
Timeliness of Antibiotic Prophylaxis for Children
with Sickle Cell Disease
Section 1. Basic Measure Information
1.A. Measure Name
Timeliness of Antibiotic Prophylaxis for Children with Sickle Cell Disease
1.B. Measure Number
0135
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
May 01, 2018 - Use of Multiple Concurrent Antipsychotics in Children
1
Use of Multiple Concurrent Antipsychotics in Children
Section 1. Basic Measure Information
1.A. Measure Name
Use of Multiple Concurrent Antipsychotics in Children
1.B. Measure Number
0126
1.C. Measure Description
Please provide a non-technical descript…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-fullreport.pdf
May 01, 2018 - Use of Higher-Than-Recommended Doses of Antipsychotics in Children and Adolescents
1
Use of Higher-than-Recommended Doses of
Antipsychotics in Children and Adolescents
Section 1. Basic Measure Information
1.A. Measure Name
Use of Higher-than-Recommended Doses of Antipsychotics in Children and Adolescents
1.B.…
-
www.ahrq.gov/sites/default/files/2024-01/malone-report.pdf
January 01, 2024 - Final Progress Report: Drug-Drug Interaction Clinical Decision Support Conference Series
Drug-Drug Interaction Clinical Decision Support
Conference Series
Investigators:
Daniel C. Malone, RPh, PhD, Principal Investigator
Mary L. Brown, PhD, Co-Investigator
Lisa E. Hines, PharmD, Co-Investigator
Amy Grizzle, Pha…